| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Omega Fund VI, L.P. | Former 10% owner | $108,674,532 | 20 Jul 2021 | ||
| Lifesciences III L.P. Clarus | 10%+ Owner | $85,501,332 | 30 Mar 2022 | ||
| Patrick J. Heron | Director | $83,243,916 | 20 Jul 2021 | ||
| Wan-Jen Hong | Chief Medical Officer | $36,000 | 18 Jul 2022 | ||
| Enoch Kariuki | Director | 11 Jan 2023 | |||
| Hugh Y. Rienhoff | Chief Executive Officer, Director | 11 Jan 2023 | |||
| Jennifer Peppe | Global Head, Clinical Operations | 11 Jan 2023 | |||
| Laura G. Eichorn | Chief Financial Officer | 11 Jan 2023 | |||
| DENNIS HENNER | Director | 11 Jan 2023 | |||
| Robert Baltera Jr. | Director | 11 Jan 2023 | |||
| Hsiangyi Chiang | Senior Vice President, Finance | 11 Jan 2023 | |||
| LAURIE KEATING | Director | 11 Jan 2023 | |||
| Matthew Plunkett | Chief Financial Officer | 15 Jul 2021 | |||
| Amy E. Tapper | Chief, Technical Operations | 11 Jan 2023 | |||
| Moghrabi Dina Chaya | Director | 11 Jan 2023 | |||
| Michael Arenberg | Chief Operating and Business Officer | 11 Jan 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|